vs
ICU MEDICAL INC（ICUI）与OneWater Marine Inc.（ONEW）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是OneWater Marine Inc.的1.4倍（$540.7M vs $380.6M），OneWater Marine Inc.净利率更高（-2.0% vs -2.9%，领先0.9%），OneWater Marine Inc.同比增速更快（1.3% vs -14.1%），ICU MEDICAL INC自由现金流更多（$36.0M vs $-78.2M），过去两年ICU MEDICAL INC的营收复合增速更高（-2.3% vs -11.7%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
OneWater Marine Inc.是美国头部休闲船舶零售企业，主营全新及二手船只、游艇、船舶零配件销售，同时提供船只维修保养、配套融资等服务，通过覆盖北美多州的经销商网络服务个人及商业休闲船艇客户。
ICUI vs ONEW — 直观对比
营收规模更大
ICUI
是对方的1.4倍
$380.6M
营收增速更快
ONEW
高出15.4%
-14.1%
净利率更高
ONEW
高出0.9%
-2.9%
自由现金流更多
ICUI
多$114.2M
$-78.2M
两年增速更快
ICUI
近两年复合增速
-11.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $380.6M |
| 净利润 | $-15.7M | $-7.7M |
| 毛利率 | 37.5% | 23.5% |
| 营业利润率 | 1.0% | -1.4% |
| 净利率 | -2.9% | -2.0% |
| 营收同比 | -14.1% | 1.3% |
| 净利润同比 | 34.0% | 35.6% |
| 每股收益（稀释后） | $-0.63 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUIONEW
| Q4 25 | $540.7M | $380.6M | ||
| Q3 25 | $537.0M | $460.1M | ||
| Q2 25 | $548.9M | $552.9M | ||
| Q1 25 | $604.7M | $483.5M | ||
| Q4 24 | $629.8M | $375.8M | ||
| Q3 24 | $589.1M | $377.9M | ||
| Q2 24 | $596.5M | $542.4M | ||
| Q1 24 | $566.7M | $488.3M |
净利润ICUIONEW
| Q4 25 | $-15.7M | $-7.7M | ||
| Q3 25 | $-3.4M | $-113.0M | ||
| Q2 25 | $35.3M | $10.7M | ||
| Q1 25 | $-15.5M | $-368.0K | ||
| Q4 24 | $-23.8M | $-12.0M | ||
| Q3 24 | $-33.0M | $-9.2M | ||
| Q2 24 | $-21.4M | $14.7M | ||
| Q1 24 | $-39.5M | $-4.0M |
毛利率ICUIONEW
| Q4 25 | 37.5% | 23.5% | ||
| Q3 25 | 37.4% | 22.6% | ||
| Q2 25 | 37.9% | 23.3% | ||
| Q1 25 | 34.7% | 22.8% | ||
| Q4 24 | 36.1% | 22.4% | ||
| Q3 24 | 34.8% | 24.0% | ||
| Q2 24 | 34.8% | 24.4% | ||
| Q1 24 | 32.7% | 24.6% |
营业利润率ICUIONEW
| Q4 25 | 1.0% | -1.4% | ||
| Q3 25 | 2.6% | -28.3% | ||
| Q2 25 | 1.9% | 5.5% | ||
| Q1 25 | 2.1% | 3.4% | ||
| Q4 24 | 6.0% | -0.5% | ||
| Q3 24 | 1.4% | 1.2% | ||
| Q2 24 | 1.3% | 7.4% | ||
| Q1 24 | -1.9% | 2.8% |
净利率ICUIONEW
| Q4 25 | -2.9% | -2.0% | ||
| Q3 25 | -0.6% | -24.5% | ||
| Q2 25 | 6.4% | 1.9% | ||
| Q1 25 | -2.6% | -0.1% | ||
| Q4 24 | -3.8% | -3.2% | ||
| Q3 24 | -5.6% | -2.4% | ||
| Q2 24 | -3.6% | 2.7% | ||
| Q1 24 | -7.0% | -0.8% |
每股收益（稀释后）ICUIONEW
| Q4 25 | $-0.63 | — | ||
| Q3 25 | $-0.14 | — | ||
| Q2 25 | $1.43 | — | ||
| Q1 25 | $-0.63 | — | ||
| Q4 24 | $-0.97 | — | ||
| Q3 24 | $-1.35 | — | ||
| Q2 24 | $-0.88 | — | ||
| Q1 24 | $-1.63 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $277.5M |
| 总资产 | $4.1B | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ICUIONEW
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $308.6M | — | ||
| Q3 24 | $312.5M | — | ||
| Q2 24 | $302.6M | — | ||
| Q1 24 | $251.4M | — |
股东权益ICUIONEW
| Q4 25 | $2.1B | $277.5M | ||
| Q3 25 | $2.1B | $285.0M | ||
| Q2 25 | $2.1B | $393.2M | ||
| Q1 25 | $2.0B | $381.6M | ||
| Q4 24 | $2.0B | $354.8M | ||
| Q3 24 | $2.0B | $360.8M | ||
| Q2 24 | $2.0B | $368.6M | ||
| Q1 24 | $2.1B | $351.7M |
总资产ICUIONEW
| Q4 25 | $4.1B | $1.4B | ||
| Q3 25 | $4.1B | $1.4B | ||
| Q2 25 | $4.1B | $1.5B | ||
| Q1 25 | $4.2B | $1.6B | ||
| Q4 24 | $4.2B | $1.6B | ||
| Q3 24 | $4.3B | $1.6B | ||
| Q2 24 | $4.3B | $1.6B | ||
| Q1 24 | $4.3B | $1.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $-76.3M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $-78.2M |
| 自由现金流率自由现金流/营收 | 6.6% | -20.6% |
| 资本支出强度资本支出/营收 | 4.6% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $91.8M | $41.6M |
8季度趋势，按日历期对齐
经营现金流ICUIONEW
| Q4 25 | $60.6M | $-76.3M | ||
| Q3 25 | $56.7M | $9.9M | ||
| Q2 25 | $11.2M | $90.8M | ||
| Q1 25 | $51.3M | $28.5M | ||
| Q4 24 | $40.2M | $-37.4M | ||
| Q3 24 | $36.1M | $27.3M | ||
| Q2 24 | $82.0M | $93.8M | ||
| Q1 24 | $45.8M | $23.7M |
自由现金流ICUIONEW
| Q4 25 | $36.0M | $-78.2M | ||
| Q3 25 | $27.6M | $7.2M | ||
| Q2 25 | $-8.5M | $88.9M | ||
| Q1 25 | $36.7M | $23.7M | ||
| Q4 24 | $16.1M | $-40.0M | ||
| Q3 24 | $16.2M | $23.2M | ||
| Q2 24 | $62.5M | $86.9M | ||
| Q1 24 | $29.9M | $13.8M |
自由现金流率ICUIONEW
| Q4 25 | 6.6% | -20.6% | ||
| Q3 25 | 5.1% | 1.6% | ||
| Q2 25 | -1.5% | 16.1% | ||
| Q1 25 | 6.1% | 4.9% | ||
| Q4 24 | 2.6% | -10.7% | ||
| Q3 24 | 2.7% | 6.1% | ||
| Q2 24 | 10.5% | 16.0% | ||
| Q1 24 | 5.3% | 2.8% |
资本支出强度ICUIONEW
| Q4 25 | 4.6% | 0.5% | ||
| Q3 25 | 5.4% | 0.6% | ||
| Q2 25 | 3.6% | 0.4% | ||
| Q1 25 | 2.4% | 1.0% | ||
| Q4 24 | 3.8% | 0.7% | ||
| Q3 24 | 3.4% | 1.1% | ||
| Q2 24 | 3.3% | 1.3% | ||
| Q1 24 | 2.8% | 2.0% |
现金转化率ICUIONEW
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.32× | 8.47× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 6.39× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
ONEW
| New Sales | $233.3M | 61% |
| Pre Owned | $70.4M | 19% |
| Service Parts Other | $68.0M | 18% |
| Finance And Insurance Income | $8.9M | 2% |
